Mirova Portfolio holdings
Mirova is a Paris-based asset manager devoted to sustainable investing and an affiliate of Natixis Investment Managers. Philippe Zaouati founded it in 2012 as a department of Natixis Asset Management (later renamed Ostrum Asset Management), and in 2014 it became a direct affiliate of Natixis Investment Managers. Mirova aims to build every portfolio to fit a climate path below 2°C, and its Althelia funds invest in the sustainable management of land and marine resources. It bought SunFunder, a Nairobi-based specialist in clean energy and climate investment in emerging markets, in 2022, and in 2020 became a mission-driven company under French law.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xylem
XYL
|
+$7.03M |
| 2 |
Trimble
TRMB
|
+$6.54M |
| 3 |
Cadence Design Systems
CDNS
|
+$5.73M |
| 4 |
Sprouts Farmers Market
SFM
|
+$5.64M |
| 5 |
Colgate-Palmolive
CL
|
+$5.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$5.51M |
| 2 |
Exponent
EXPO
|
+$2.07M |
| 3 |
Cisco
CSCO
|
+$2.03M |
| 4 |
Sunrun
RUN
|
+$1.84M |
| 5 |
Bright Horizons
BFAM
|
+$1.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.01% |
| 2 | Healthcare | 17.43% |
| 3 | Industrials | 16.94% |
| 4 | Materials | 8.62% |
| 5 | Consumer Discretionary | 6.71% |
Similar funds
Mirova's Q2 2025 Portfolio in Review
As of Q2 2025, Mirova held 141 positions worth $709M, up 28% from $556M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Mirova deployed $113M of net new capital in Q2 2025, opening 7 new positions and adding to 61 existing holdings. Its largest new stake was Hubbell: 5,000 shares worth $2.04M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $5.51M trimmed.
- Mirova's largest Q2 2025 buy was Hubbell: 5,000 shares worth $2.04M.
- Mirova added most to Xylem in Q2 2025, an estimated $7.03M increase.
- Mirova's biggest Q2 2025 reduction was Thermo Fisher Scientific, cutting an estimated $5.51M.
- Mirova fully exited Omnicom Group in Q2 2025, selling an estimated $659K.
- Mirova's ten largest holdings make up 44% of its $709M portfolio in Q2 2025.
- Mirova opened 7 new positions and closed 22 in Q2 2025.
- Mirova's portfolio value rose 28% quarter-over-quarter to $709M.
Based on Mirova's 13F filing for Q2 2025, filed 13 Aug 2025.